{"result": "(\"entity\"<|>ENZIMAS PANCREÁTICAS<|>EVENT<|>Pancreatic enzymes are supplements that aid in digestion and are often administered to patients with cystic fibrosis to improve nutrient absorption.)\n##\n(\"entity\"<|>GASTROSTOMÍA<|>EVENT<|>Gastrostomy is a surgical procedure to create an opening in the stomach for nutritional support, commonly used in patients requiring long-term enteral nutrition.)\n##\n(\"entity\"<|>SONDA NASOGÁSTRICA<|>EVENT<|>A nasogastric tube is a flexible tube inserted through the nose into the stomach for feeding or medication administration, often used in patients with difficulty swallowing.)\n##\n(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutrition refers to the process of providing or obtaining the food necessary for health and growth, particularly important in managing chronic conditions like cystic fibrosis.)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>ENZIMAS PANCREÁTICAS<|>Pancreatic enzymes are essential for the digestion of nutrients in patients with cystic fibrosis<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN<|>NUTRICIÓN ENTERAL<|>Enteral nutrition is a specific method of providing nutrition directly to the gastrointestinal tract<|>7)\n##\n(\"relationship\"<|>GASTROSTOMÍA<|>NUTRICIÓN ENTERAL<|>Gastrostomy is often performed to facilitate enteral nutrition in patients who cannot eat by mouth<|>6)\n##\n(\"relationship\"<|>SONDA NASOGÁSTRICA<|>NUTRICIÓN<|>Nasogastric tubes are used for nutritional support in patients who have difficulty swallowing<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: enso), la fuerza muscular o el balance nitrogenado y algunos aspectos de la calidad de vida como la sensación de bienestar o la actividad.\n\nSe suele aportar el 40-50% de las calorías totales estimadas para todo el día. En general, las enzimas pancreáticas deben administrarse antes y al final de la ad-\n\nministración. En el caso de levantarse por la noche sería conveniente infundir una dosis extra de enzimas a través de los sistemas de nutrición enteral (NE). Si se administra por bolos, suelen ser necesarias mayores dosis al incrementar el flujo de aporte de grasa en el tiempo. Se debe controlar la glucemia y tratar la hiperglucemia si fuera necesario con insulina. En caso de ingreso hospitalario y administración continua, lo ideal es la administración de las enzimas cada 3-4 horas. No se deben mezclar las enzimas con las fórmulas de NE.\n\nDado que el soporte nutricional por sonda se debe mantener durante largos períodos (meses o años) se suele emplear la gastrostomía (generalmente colocada percutáneamente por endoscopia o radioscopia), ya que son bien toleradas, conllevan escasas complicaciones y suelen ser mejor aceptadas que la sonda nasogástrica, permitiendo una relación social más satisfactoria. Aunque la administración suele ser nocturna (para permitir una alimentación normal durante el día) se deben individualizar las pautas de infusión de nutrición enteral adaptándolas a las preferencias de los pacientes.\n\n### 5.2.3. Tipos de preparados para la suplementación oral y nutrición enteral en la fibrosis quística\n\nLos preparados más empleados son los que aportan una alta densidad energética (en fórmulas líquidas de 1,5 a 2 kcal/ml). Son de elección las dietas poliméricas\n\n| Tabla 10. Recomendaciones de empleo de dieta, suplementos y nutrición enteral en la fibrosis quística en función del estado nutricional. |\n|--------------------------------------------------------------------------------------------------------------------------------------------|\n| Estado nutricional | Puntos de corte para intensificar el soporte nutricional |\n|                    | Niños < 2 años | Niños 2-18 años | Adultos > 18 años |\n|--------------------|-----------------|-----------------|--------------------|\n| Estado nutricional normal: objetivo a alcanzar | Peso y talla ≥ 50 pc | IMC pc ≥ 50 | IMC 18,5 a 22 kg/m² en mujeres y 18,5 a 23 kg/m² en varones No pérdida de peso |\n|                    | Solo recomendaciones dietéticas preventivas |\n|--------------------|-----------------|-----------------|--------------------|\n| Estado nutricional alterado | Falta de medro: peso y talla entre 10 y 50 pc | IMC pc entre 10 y 50 Pérdida de peso en 2-4 meses No ganancia de peso en 2 meses | IMC < 18,5 kg/m² o Pérdida > 5% en 2 meses |\n|                    | Modificación de la dieta y/o suplementos nutricionales orales |\n|--------------------|-----------------|-----------------|--------------------|\n| Desnutrición persistente | Falta de medro persistente y talla < 10 pc | IMC persistentemente bajo (< 10 pc) Pérdida de peso de dos puntos en pc y detención del crecimiento | IMC < 18,5 kg/m² mantenido en el tiempo Pérdida de peso continuada (> 5%) y fallo de crecimiento |\n|                    | Nutrición enteral por sonda |\n\nPc: Percentil.\nModificada de Turk D et al.52.\n---\n# Tema 35. Soporte nutricional en el paciente con patología pulmonar, enfermedad pulmonar... 571\n\n(aportan proteínas enteras) e hiperproteicas (especialmente si existe estrés metabólico elevado). Los preparados pediátricos se pueden emplear hasta los 5 años y a partir de esa edad son adecuados los preparados para adultos. Si coexiste la FQ con diabetes mellitus, nuestro grupo recomienda emplear fórmulas «específicas para diabetes» que aporten un contenido en lípidos alto (entre el 38 y el 50% del VCT) y, en general, hipercalóricas e hiperproteicas. No obstante, se debe individualizar la fórmula que se va a emplear dependiendo de la coexistencia de otras comorbilidades y características individuales de los pacientes².\n\nExisten también fórmulas «para personas con FQ» que incorporan como fuente de AG, además de AG esenciales, AG de la serie ω-3. Son fórmulas hiperproteicas e hipercalóricas, adicionan triglicéridos con AG de cadena media y ciertos micronutrientes a dosis más altas que las habituales. No obstante, son necesarios estudios aleatorizados y controlados que los comparen con otras fórmulas para poder realizar recomendaciones basadas en pruebas.\n\nCuando las diet\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>FIBROSIS QUÍSTICA<|>EVENT<|>Fibrosis quística is a genetic disorder that affects the lungs and digestive system, requiring nutritional support and enzyme supplementation for management.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Enteral nutrition is a method of delivering nutrients directly to the stomach or intestines, often used for patients with conditions like cystic fibrosis.)\n##\n(\"entity\"<|>TURK D ET AL.<|>PERSON<|>Turk D et al. is a reference to a group of researchers or authors who have contributed to the guidelines on nutritional support in cystic fibrosis.)\n##\n(\"entity\"<|>DIABETES MELLITUS<|>EVENT<|>Diabetes mellitus is a chronic condition that can coexist with cystic fibrosis, affecting nutritional needs and management strategies.)\n##\n(\"entity\"<|>AG<|>EVENT<|>AG refers to fatty acids, which are important in dietary formulations for patients with cystic fibrosis.)\n##\n(\"entity\"<|>AG ESENCIALES<|>EVENT<|>Essential fatty acids are necessary fats that the body cannot produce on its own, important in dietary management for cystic fibrosis patients.)\n##\n(\"entity\"<|>AG DE CADENA MEDIA<|>EVENT<|>Medium-chain triglycerides are a type of fat that can be beneficial in the dietary management of cystic fibrosis.)\n##\n(\"relationship\"<|>FIBROSIS QUÍSTICA<|>NUTRICIÓN ENTERAL<|>Nutritional support through enteral nutrition is crucial for managing cystic fibrosis patients<|>8)\n##\n(\"relationship\"<|>TURK D ET AL.<|>FIBROSIS QUÍSTICA<|>Turk D et al. provides guidelines for nutritional support in patients with cystic fibrosis<|>7)\n##\n(\"relationship\"<|>DIABETES MELLITUS<|>NUTRICIÓN ENTERAL<|>Patients with cystic fibrosis and diabetes mellitus require specific dietary formulations for effective management<|>6)\n##\n(\"relationship\"<|>AG<|>FIBROSIS QUÍSTICA<|>Fatty acids are important components in the dietary management of cystic fibrosis<|>5)\n##\n(\"relationship\"<|>AG ESENCIALES<|>FIBROSIS QUÍSTICA<|>Essential fatty acids are critical in the dietary formulations for cystic fibrosis patients<|>5)\n##\n(\"relationship\"<|>AG DE CADENA MEDIA<|>FIBROSIS QUÍSTICA<|>Medium-chain triglycerides are recommended for dietary management in cystic fibrosis<|>5)\n<|COMPLETE|>"}]}